NasdaqGS - Nasdaq Real Time Price USD
Spero Therapeutics, Inc. (SPRO)
2.5000
+0.3700
+(17.37%)
At close: May 30 at 4:00:01 PM EDT
2.5099
+0.01
+(0.40%)
After hours: May 30 at 7:59:50 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-33,384
-23,444
-32,995
-7,731
-64,347
Investing Cash Flow
10,532
--
0
33,807
7,672
Financing Cash Flow
6,617
0
221
-29,553
84,050
End Cash Position
48,887
52,889
76,333
109,107
112,584
Income Tax Paid Supplemental Data
--
99
2,212
0
--
Issuance of Capital Stock
12,808
0
221
24,512
35,368
Free Cash Flow
-33,384
-23,444
-32,995
-7,731
-64,347
12/31/2021 - 11/2/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASBP Aspire Biopharma Holdings, Inc.
0.4301
-28.60%
ALZN Alzamend Neuro, Inc.
3.8300
-29.60%
IMNN Imunon, Inc.
2.4900
+25.13%
PLRZ Polyrizon Ltd.
0.9131
-26.95%
VERU Veru Inc.
0.5082
-0.20%
RCKT Rocket Pharmaceuticals, Inc.
2.5100
-4.20%
ORIC ORIC Pharmaceuticals, Inc.
8.17
+2.51%
TNXP Tonix Pharmaceuticals Holding Corp.
39.78
-5.33%
MRUS Merus N.V.
56.07
+1.26%
ITOS iTeos Therapeutics, Inc.
10.02
-0.10%